| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |